| 1331636 | COPD13_H | Chronic obstructive pulmonary disease QTL 13 (human) | 1.56 | | Chronic airflow obstruction | post-BD FEV1 minus pre-BD FEV1 | 4 | 57681817 | 183160300 | Human | n/a | region | qtl |
| 2289563 | BW441_H | Body weight QTL 441 (human) | 2.66 | .0005 | Body weight | BMI | 4 | 99434973 | 185151317 | Human | n/a | region | qtl |
| 1559222 | SAPOA2_H | Serum apolipoprotein A level QTL 2 (human) | 2.35 | | Apolipoprotein level | apolipoprotein A-II level | 4 | 108376545 | 190440336 | Human | n/a | region | qtl |
| 1643293 | BW197_H | Body weight QTL 197 (human) | 1.71 | .002 | Body weight | BMI | 4 | 128751555 | 154751555 | Human | n/a | region | qtl |
| 1643443 | SLIPL3_H | Serum lipid level QTL 3 (human) | 2.07 | .001 | Lipid level | | 4 | 130501052 | 156501052 | Human | n/a | region | qtl |
| 1643249 | BW135_H | Body weight QTL 135 (human) | 1.92 | | Body weight | | 4 | 130501052 | 156501052 | Human | n/a | region | qtl |
| 1643255 | BW128_H | Body Weight QTL 128 (human) | .88 | .022 | Body weight | body mass index | 4 | 130501052 | 156501052 | Human | n/a | region | qtl |
| 1559360 | BW79_H | Body weight QTL 79 (human) | 1.89 | .005 | Body weight | body mass index | 4 | 145336879 | 171336879 | Human | n/a | region | qtl |
| 2292886 | MYI20_H | Myocardial infarction susceptibility QTL 20 (human) | | | Myocardial infarction susceptibility | early-onset | 4 | 145336879 | 171336879 | Human | n/a | region | qtl |
| 2292901 | MYI21_H | Myocardial infarction susceptibility QTL 21 (human) | | | Myocardial infarction susceptibility | early-onset | 4 | 145336879 | 171336879 | Human | n/a | region | qtl |
| 2314741 | GLUCO78_H | Glucose level QTL 78 (human) | .66 | .01 | Glucose level | non-insulin dependent | 4 | 145353344 | 171353344 | Human | n/a | region | qtl |